Analyst Ratings (USA)
The Amercan market outlook remains mixed, with analysts showing optimism toward technology, healthcare and industrial stocks, while consumer discretionary and financial services face greater caution. Selective upgrades and higher price targets suggest confidence in earnings growth, although valuation pressures and economic uncertainty remain concerns. Overall, analysts favour companies with strong fundamentals, sustainable profitability and attractive growth prospects amid continued market volatility.
Updates (282)
Ameris Bancorp (ABCB) — Keefe Bruyette & Woods maintained its Outperform rating with a price target of $95.00.
Abbott Laboratories (ABT) — Leerink Partners upgraded the stock from Market Perform to Outperform, with a price target of $124.00.
AECOM (ACM) — Truist updated its price target from $75.00 to $97.00, maintaining a Buy rating.
AECOM (ACM) — RBC Capital Markets raised its price target from $89.00 to $102.00, maintaining an Outperform rating.
Accenture (ACN) — Bank of America resumed coverage with a Buy rating and a price target of $288.00.
Accenture (ACN) — Guggenheim maintained its Buy rating.
Analog Devices (ADI) — Raymond James maintained its Outperform rating.
Automatic Data Processing (ADP) — Bank of America resumed coverage with a Buy rating and a price target of $345.00.
ADARx Pharmaceuticals (ADRX) — JPMorgan lowered its price target from $38.00 to $36.00, maintaining an Overweight rating.
ADTRAN (ADTN) — Argus downgraded the stock from Hold to Sell.
Atlas Energy Solutions (AESI) — Raymond James set a price target of $12.00, with an Outperform rating.
Agilon Health (AGL) — Bernstein raised its price target from $125.00 to $138.00, maintaining an Outperform rating.
Arthur J. Gallagher & Co. (AJG) — Wells Fargo downgraded the stock from Overweight to Equal Weight and adjusted its price target from $312.00 to $294.00.
Amgen (AMGN) — Piper Sandler updated its price target from $457.00 to $542.00, maintaining an Overweight rating.
Amylyx Pharmaceuticals (AMLX) — H.C. Wainwright maintained its Buy rating with a price target of $55.00.
Amrize (AMRZ) — JPMorgan lowered its price target from $48.00 to $46.00, maintaining a Neutral rating.
Arista Networks (ANET) — Morgan Stanley set a price target of $250.00.
Aon (AON) — Wells Fargo downgraded the stock from Overweight to Equal Weight, with a price target of $364.00.
Anthropic (ANT) — Citizens initiated coverage with a Market Outperform rating and a price target of $125.00.
Anthropic (ANT) — Melius initiated coverage with a Buy rating and a price target of $155.00.
Anthropic (ANT) — Needham initiated coverage with a Buy rating and a price target of $150.00.
Anthropic (ANT) — Wolfe Research initiated coverage with a Outperform rating and a price target of $135.00.
AppLovin (APP) — StoneX raised its price target from $440.00 to $469.00, maintaining a Buy rating.
Aramark (ARMK) — Citigroup lowered its price target from $75.50 to $72.50, maintaining a Buy rating.
AST SpaceMobile (ASTS) — B. Riley Financial upgraded the stock from Neutral to Buy, with a price target of $48.00.
AxoGen (AXGN) — Leerink Partners raised its price target from $56.00 to $65.00, maintaining an Outperform rating.
Alibaba Group (BABA) — Susquehanna maintained its Positive rating.
Alibaba Group (BABA) — Barclays set a price target of $155.00, with an Overweight rating.
Alibaba Group (BABA) — Jefferies Financial Group set a price target of $161.00, with a Buy rating.
Braskem (BAK) — UBS lowered its price target from $1.50 to $0.75, maintaining a Sell rating.
Bath & Body Works (BBWI) — Jefferies Financial Group maintained its Hold rating with a price target of $21.00.
Bloom Energy (BE) — BMO Capital Markets upgraded the stock from Market Perform to Outperform, with a price target of $230.00.
Biohaven (BHVN) — JPMorgan raised its price target from $14.00 to $35.00, maintaining an Overweight rating.
Biogen (BIIB) — H.C. Wainwright set a price target of $270.00, with a Buy rating.
BILL (BILL) — TD Cowen raised its price target from $66.00 to $76.00, maintaining a Buy rating.
BILL (BILL) — Susquehanna downgraded the stock from Positive to Neutral, with a price target of $73.00.
Bullish (BLSH) — JPMorgan lowered its price target from $28.00 to $26.00, maintaining a Neutral rating.
Bullish (BLSH) — Rosenblatt Securities lowered its price target from $30.00 to $22.00, maintaining a Neutral rating.
Bullish (BLSH) — Canaccord Genuity lowered its price target from $45.00 to $40.00, maintaining a Buy rating.
BioNTech (BNTX) — JPMorgan raised its price target from $92.00 to $93.00, maintaining a Neutral rating.
BOX (BOX) — UBS upgraded the stock from Neutral to Buy and adjusted its price target from $37.00 to $55.00.
BellRing Brands (BRBR) — DA Davidson raised its price target from $15.00 to $17.00, maintaining a Buy rating.
BellRing Brands (BRBR) — Stifel raised its price target from $15.00 to $18.00, maintaining a Buy rating.
BellRing Brands (BRBR) — TD Cowen raised its price target from $9.00 to $15.00, maintaining a Hold rating.
BellRing Brands (BRBR) — UBS raised its price target from $9.50 to $15.00, maintaining a Neutral rating.
BellRing Brands (BRBR) — JPMorgan raised its price target from $15.00 to $18.00, maintaining an Overweight rating.
BellRing Brands (BRBR) — Bernstein raised its price target from $13.00 to $15.00, maintaining a Market Perform rating.
Brown & Brown (BRO) — Wells Fargo upgraded the stock from Equal Weight to Overweight and adjusted its price target from $68.00 to $82.00.
BRT Apartments (BRT) — Citizens Jmp lowered its price target from $20.00 to $17.00, maintaining a Market Outperform rating.
CAE (CAE) — Morgan Stanley upgraded the stock from Underweight to Equal Weight.
Coca-Cola Europacific Partners (CCEP) — Barclays raised its price target from $124.00 to $130.00, maintaining an Overweight rating.
CG Oncology (CGON) — Guggenheim raised its price target from $89.00 to $120.00, maintaining a Buy rating.
Cognition Therapeutics (CGTX) — H.C. Wainwright maintained its Buy rating with a price target of $3.00.
Church & Dwight (CHD) — Oppenheimer raised its price target from $120.00 to $124.00, maintaining an Outperform rating.
Cigna Group (CI) — RBC Capital Markets raised its price target from $337.00 to $346.00, maintaining an Outperform rating.
Cummins (CMI) — Argus lowered its price target from $770.00 to $609.00, maintaining a Buy rating.
Cheniere Energy Partners (CQP) — RBC Capital Markets raised its price target from $65.00 to $68.00, maintaining a Sector Perform rating.
CRH (CRH) — JPMorgan lowered its price target from $115.00 to $110.00, maintaining an Overweight rating.
CoinShares (CSHR) — Keefe Bruyette & Woods updated its price target.
Cognizant Technology Solutions (CTSH) — Bank of America resumed coverage with a Neutral rating and a price target of $70.00.
Corteva (CTVA) — Barclays resumed coverage with an Equal Weight rating and a price target of $11.00.
Walt Disney (DIS) — Morgan Stanley raised its price target from $133.00 to $138.00, maintaining an Overweight rating.
Dolby Laboratories (DLB) — Baird lowered its price target from $62.00 to $60.00, maintaining a Neutral rating.
Docusign (DOCU) — UBS initiated coverage with a Neutral rating and adjusted its price target from $70.00 to $85.00.
Duke Energy (DUK) — BMO Capital Markets raised its price target from $128.00 to $138.00, maintaining an Outperform rating.
Duke Energy (DUK) — Piper Sandler set a price target of $138.00.
Duke Energy (DUK) — TD Cowen set a price target of $138.00.
Ecolab (ECL) — BMO Capital Markets maintained its Outperform rating.
Ecolab (ECL) — Mizuho raised its price target from $327.00 to $350.00, maintaining an Outperform rating.
Ecolab (ECL) — Barclays raised its price target from $300.00 to $385.00, maintaining an Overweight rating.
Equifax (EFX) — Barclays raised its price target from $155.00 to $185.00, maintaining an Equal Weight rating.
Edison International (EIX) — JPMorgan updated its price target.
Elanco Animal Health (ELAN) — Barclays raised its price target from $30.00 to $32.00, maintaining an Overweight rating.
EquipmentShare.com (EQPT) — UBS lowered its price target from $22.00 to $17.00, maintaining a Neutral rating.
Eagle Materials (EXP) — JPMorgan lowered its price target from $200.00 to $190.00, maintaining a Neutral rating.
Expeditors International of Washington (EXPD) — Citizens Jmp upgraded the stock from Market Perform to Outperform, with a price target of $240.00.
Expeditors International of Washington (EXPD) — Morgan Stanley raised its price target from $100.00 to $115.00, maintaining an Underweight rating.
Expeditors International of Washington (EXPD) — Bank of America raised its price target from $230.00 to $234.00, maintaining a Buy rating.
Expeditors International of Washington (EXPD) — UBS raised its price target from $245.00 to $252.00, maintaining a Buy rating.
Ford Motor (F) — DZ Bank upgraded the stock from Hold to Buy, with a price target of $15.00.
Figure Technology Solutions (FIGR) — Needham & Company LLC maintained its Buy rating with a price target of $50.00.
Fomento Economico Mexicano (FMX) — Barclays upgraded the stock from Equal Weight to Overweight, with a price target of $155.00.
Finance of America Companies (FOA) — B. Riley Financial lowered its price target from $32.00 to $25.00, maintaining a Buy rating.
JFrog (FROG) — TD Cowen maintained its Buy rating.
Golub Capital BDC (GBDC) — Wells Fargo lowered its price target from $13.00 to $12.00, maintaining an Overweight rating.
Gladstone Capital (GLAD) — Raymond James maintained its Market Perform rating.
Global-e Online (GLBE) — Piper Sandler maintained its Overweight rating with a price target of $52.00.
Global-e Online (GLBE) — UBS lowered its price target from $54.00 to $50.00, maintaining a Buy rating.
Global-e Online (GLBE) — Bank of America lowered its price target from $52.00 to $50.00, maintaining a Buy rating.
Global-e Online (GLBE) — Morgan Stanley lowered its price target from $50.00 to $49.00, maintaining an Overweight rating.
Global-e Online (GLBE) — Raymond James maintained its Outperform rating.
Generac (GNRC) — TD Cowen raised its price target from $285.00 to $295.00, maintaining a Buy rating.
Global Payments (GPN) — Truist set a price target of $86.00.
Gulfport Energy (GPOR) — UBS lowered its price target from $217.00 to $210.00, maintaining a Buy rating.
Green Plains (GPRE) — Oppenheimer maintained its Outperform rating.
HawkEye 360 (HAWK) — William Blair maintained its Outperform rating.
HawkEye 360 (HAWK) — Oppenheimer initiated coverage with an Outperform rating and a price target of $30.00.
Harley-Davidson (HOG) — StoneX initiated coverage with a Buy rating and a price target of $40.00.
Humana (HUM) — Morgan Stanley raised its price target from $370.00 to $475.00, maintaining an Equal Weight rating.
International Paper (IP) — Argus downgraded the stock from Buy to Hold.
Innate Pharma (IPHA) — Leerink Partners downgraded the stock from Outperform to Market Perform, with a price target of $1.00.
Quince Therapeutics (IRLA) — Cantor Fitzgerald maintained its Overweight rating with a price target of $70.00.
Disc Medicine (IRON) — Cantor Fitzgerald maintained its Overweight rating with a price target of $170.00.
ITG (ITG) — UBS lowered its price target from $18.00 to $10.00, maintaining a Buy rating.
JBS (JBS) — UBS lowered its price target from $17.00 to $16.50, maintaining a Buy rating.
JD.com (JD) — Susquehanna lowered its price target from $30.00 to $28.00, maintaining a Neutral rating.
J & J Snack Foods (JJSF) — StoneX raised its price target from $120.00 to $125.00, maintaining a Buy rating.
Jumia Technologies (JMIA) — StoneX set a price target of $13.00, maintaining a Buy rating.
Jumia Technologies (JMIA) — Cantor Fitzgerald lowered its price target from $9.00 to $5.00, maintaining an Overweight rating.
Kodiak AI (KDK) — Needham & Company LLC maintained its Buy rating with a price target of $4.00.
OrthoPediatrics (KIDS) — Piper Sandler updated its price target from $30.00 to $45.00, maintaining an Overweight rating.
Kingstone Companies (KINS) — Piper Sandler initiated coverage with an Overweight rating and a price target of $24.00.
Kodiak Sciences (KOD) — JPMorgan raised its price target from $124.00 to $128.00, maintaining an Overweight rating.
Kornit Digital (KRNT) — Needham & Company LLC maintained its Buy rating with a price target of $23.00.
Laser Photonics (LASE) — H.C. Wainwright initiated coverage with a Buy rating and a price target of $2.00.
LGN (LGN) — Tigress Financial lowered its price target from $130.00 to $85.00, maintaining a Buy rating.
Linde (LIN) — Kepler Capital Markets upgraded the stock from Hold to Buy and adjusted its price target from $490.00 to $601.00.
Cheniere Energy (LNG) — RBC Capital Markets raised its price target from $319.00 to $373.00, maintaining an Outperform rating.
Athira Pharma (LONA) — Mizuho lowered its price target from $13.00 to $12.00, maintaining an Outperform rating.
Lowe’s Companies (LOW) — RBC Capital Markets lowered its price target from $231.00 to $229.00, maintaining a Sector Perform rating.
Lowe’s Companies (LOW) — Barclays lowered its price target from $260.00 to $255.00, maintaining an Overweight rating.
Lowe’s Companies (LOW) — UBS lowered its price target from $275.00 to $269.00, maintaining a Buy rating.
Lowe’s Companies (LOW) — DA Davidson maintained its Neutral rating with a price target of $245.00.
Lowe’s Companies (LOW) — Baird lowered its price target from $270.00 to $250.00, maintaining an Outperform rating.
Lowe’s Companies (LOW) — Truist lowered its price target from $254.00 to $240.00, maintaining a Buy rating.
Lowe’s Companies (LOW) — Mizuho lowered its price target from $250.00 to $248.00, maintaining an Outperform rating.
Microbot Medical (MBOT) — B. Riley Financial lowered its price target from $4.00 to $3.00, maintaining a Buy rating.
MongoDB (MDB) — BTIG Research maintained its Buy rating.
MongoDB (MDB) — Bank of America lowered its price target from $540.00 to $450.00, maintaining a Buy rating.
MongoDB (MDB) — UBS resumed coverage with a Buy rating and a price target of $450.00.
MongoDB (MDB) — Barclays initiated coverage with an Overweight rating.
MongoDB (MDB) — Needham & Company LLC initiated coverage with a Buy rating.
MongoDB (MDB) — Susquehanna downgraded the stock to Hold.
MongoDB (MDB) — Citigroup upgraded the stock from Market Outperform to Outperform.
Medtronic (MDT) — BTIG Research raised its price target from $99.00 to $109.00, maintaining a Buy rating.
MercadoLibre (MELI) — Bank of America lowered its price target from $2,400.00 to $2,000.00, maintaining a Buy rating.
McGraw Hill (MH) — Morgan Stanley raised its price target from $14.00 to $15.00, maintaining an Overweight rating.
McGraw Hill (MH) — Needham & Company LLC maintained its Buy rating with a price target of $19.00.
McGraw Hill (MH) — BTIG Research maintained its Buy rating with a price target of $17.00.
MINISO Group (MNSO) — JPMorgan lowered its price target from $16.00 to $14.00, maintaining an Overweight rating.
Modine Manufacturing (MOD) — DA Davidson maintained its Buy rating with a price target of $235.00.
Modine Manufacturing (MOD) — Cantor Fitzgerald raised its price target from $178.00 to $200.00, maintaining an Overweight rating.
Modine Manufacturing (MOD) — Oppenheimer raised its price target from $215.00 to $240.00, maintaining an Outperform rating.
Modine Manufacturing (MOD) — KeyCorp maintained its Overweight rating.
Marsh & McLennan Companies (MRSH) — Wells Fargo upgraded the stock from Equal Weight to Overweight and adjusted its price target from $197.00 to $235.00.
Microsoft (MSFT) — H.C. Wainwright upgraded the stock from Neutral to Buy.
MSG Rangers (MSGR) — BTIG Research raised its price target from $257.00 to $313.00, maintaining a Buy rating.
MSG Rangers (MSGR) — Guggenheim raised its price target from $278.00 to $299.00, maintaining a Buy rating.
SOLV Energy (MWH) — Guggenheim lowered its price target from $50.00 to $42.00, maintaining a Buy rating.
NiSource (NI) — Bank of America raised its price target from $45.00 to $48.00, maintaining a Buy rating.
NiSource (NI) — JPMorgan resumed coverage with an Overweight rating and a price target of $53.00.
Terra Innovatum Global S.R.L. (NKLR) — H.C. Wainwright maintained its Buy rating.
NXP Semiconductors (NXPI) — StoneX initiated coverage with a Buy rating and a price target of $340.00.
Norcros (NXR) — Shore Capital Group maintained its House Stock rating.
Oaktree Specialty Lending (OCSL) — Wells Fargo maintained its Positive rating.
Oaktree Specialty Lending (OCSL) — Wells Fargo lowered its price target from $12.00 to $11.00, maintaining an Equal Weight rating.
BeOne Medicines (ONC) — JPMorgan raised its price target from $445.00 to $460.00, maintaining an Overweight rating.
Oncolytics Biotech (ONCY) — H.C. Wainwright maintained its Buy rating.
Oric Pharmaceuticals (ORIC) — H.C. Wainwright lowered its price target from $27.00 to $20.00, maintaining a Buy rating.
Oruka Therapeutics (ORKA) — Jefferies Financial Group set a price target of $133.00, with a Buy rating.
Oncobiologics (OTLK) — Piper Sandler initiated coverage with an Overweight rating.
Owlet (OWLT) — William Blair maintained its Outperform rating.
Owlet (OWLT) — UBS maintained its Outperform rating.
Everpure (P) — Needham & Company LLC lowered its price target from $185.00 to $150.00, maintaining a Buy rating.
Everpure (P) — Guggenheim maintained its Buy rating with a price target of $215.00.
Everpure (P) — UBS raised its price target from $88.00 to $89.00, maintaining a Sell rating.
Everpure (P) — Piper Sandler updated its price target from $162.00 to $166.00, maintaining an Overweight rating.
Everpure (P) — Barclays lowered its price target from $132.00 to $115.00, maintaining an Equal Weight rating.
Everpure (P) — TD Cowen maintained its Buy rating with a price target of $170.00.
Everpure (P) — Wedbush set a price target of $155.00.
Everpure (P) — Evercore maintained its Outperform rating.
Palo Alto Networks (PANW) — RBC Capital Markets maintained its Outperform rating with a price target of $475.00.
Palo Alto Networks (PANW) — Citigroup raised its price target from $440.00 to $445.00, maintaining a Buy rating.
Palo Alto Networks (PANW) — Wells Fargo lowered its price target from $525.00 to $510.00, maintaining an Overweight rating.
Palo Alto Networks (PANW) — Barclays raised its price target from $375.00 to $385.00, maintaining an Overweight rating.
Palo Alto Networks (PANW) — Piper Sandler updated its price target from $410.00 to $450.00, maintaining an Overweight rating.
Palo Alto Networks (PANW) — Bank of America raised its price target from $420.00 to $430.00, maintaining a Buy rating.
Palo Alto Networks (PANW) — Northland Securities raised its price target from $360.00 to $379.00, maintaining a Market Perform rating.
Palo Alto Networks (PANW) — UBS raised its price target from $390.00 to $400.00, maintaining a Neutral rating.
Palo Alto Networks (PANW) — JPMorgan raised its price target from $384.00 to $415.00, maintaining an Overweight rating.
Palo Alto Networks (PANW) — Baird raised its price target from $420.00 to $465.00, maintaining an Outperform rating.
Palo Alto Networks (PANW) — Rosenblatt Securities raised its price target from $415.00 to $460.00, maintaining a Buy rating.
Palo Alto Networks (PANW) — Bernstein raised its price target from $351.00 to $368.00, maintaining a Market Perform rating.
Palo Alto Networks (PANW) — Needham & Company LLC maintained its Buy rating with a price target of $425.00.
Palo Alto Networks (PANW) — BTIG Research raised its price target from $425.00 to $442.00, maintaining a Buy rating.
Palo Alto Networks (PANW) — Mizuho raised its price target from $415.00 to $440.00, maintaining an Outperform rating.
Palo Alto Networks (PANW) — Susquehanna raised its price target from $415.00 to $425.00, maintaining a Positive rating.
Palo Alto Networks (PANW) — DA Davidson raised its price target from $420.00 to $430.00, maintaining a Buy rating.
Paychex (PAYX) — Bank of America resumed coverage with a Neutral rating and a price target of $120.00.
Pacific Gas & Electric (PCG) — JPMorgan raised its price target from $17.00 to $19.00, maintaining an Overweight rating.
PDD (PDD) — Jefferies Financial Group set a price target of $120.00, with a Buy rating.
Progressive (PGR) — Citigroup lowered its price target from $261.00 to $260.00, maintaining a Buy rating.
Progressive (PGR) — Wells Fargo lowered its price target from $196.00 to $194.00, maintaining an Underweight rating.
Progressive (PGR) — Bank of America lowered its price target from $262.00 to $261.00, maintaining a Buy rating.
Parker-Hannifin (PH) — Susquehanna maintained its Positive rating.
Phreesia (PHR) — DA Davidson raised its price target from $13.00 to $15.00, maintaining a Buy rating.
PICS (PICS) — Mizuho lowered its price target from $16.00 to $8.00, maintaining an Outperform rating.
Pantheon Infrastructure (PINT) — Canaccord Genuity downgraded the stock to Hold.
Planet Labs PBC (PL) — Oppenheimer initiated coverage with an Outperform rating and a price target of $18.00.
Promis Neurosciences (PMN) — H.C. Wainwright maintained its Buy rating with a price target of $18.00.
Prenetics Global (PRE) — B. Riley Financial lowered its price target from $37.00 to $31.00, maintaining a Buy rating.
Primoris Services (PRIM) — Jefferies Financial Group downgraded the stock from Buy to Hold and adjusted its price target from $99.00 to $67.00.
Privia Health Group (PRVA) — RBC Capital Markets raised its price target from $31.00 to $32.00, maintaining an Outperform rating.
PayPal (PYPL) — Susquehanna maintained its Positive rating.
Roblox (RBLX) — Bank of America raised its price target from $45.00 to $48.00, maintaining a Neutral rating.
Redwire (RDW) — Oppenheimer initiated coverage with a Market Perform rating.
Reinsurance Group of America (RGA) — UBS upgraded the stock from Neutral to Buy and adjusted its price target from $236.00 to $325.00.
Cartesian Therapeutics (RNAC) — H.C. Wainwright maintained its Buy rating with a price target of $25.00.
Construction Partners (ROAD) — Truist set a price target of $90.00.
Rockwell Automation (ROK) — Oppenheimer maintained its Market Perform rating.
Rockwell Automation (ROK) — DA Davidson maintained its Neutral rating with a price target of $450.00.
Rockwell Automation (ROK) — Mizuho raised its price target from $375.00 to $415.00, maintaining a Neutral rating.
Rockwell Automation (ROK) — KeyCorp maintained its Overweight rating.
Red Robin Gourmet Burgers (RRGB) — Craig Hallum raised its price target from $14.50 to $15.50, maintaining a Buy rating.
Research Solutions (RSSS) — Maxim Group downgraded the stock from Buy to Hold.
Scribe Therapeutics (SCTX) — H.C. Wainwright maintained its Buy rating with a price target of $60.00.
Septerna (SEPN) — JPMorgan raised its price target from $48.00 to $51.00, maintaining an Overweight rating.
Super Group (SGHC) (SGHC) — Rothschild & Co Redburn initiated coverage with a Buy rating and a price target of $15.00.
Signet Jewelers (SIG) — Raymond James maintained its Outperform rating.
Semtech (SMTC) — Susquehanna lowered its price target from $200.00 to $170.00, maintaining a Positive rating.
Synopsys (SNPS) — Barclays initiated coverage with an Overweight rating and a price target of $640.00.
Southern (SO) — Jefferies Financial Group maintained its Hold rating.
Spire (SR) — Wells Fargo raised its price target from $93.00 to $94.00, maintaining an Overweight rating.
Spire (SR) — Jefferies Financial Group downgraded the stock from Buy to Hold, with a price target of $94.00.
Sarepta Therapeutics (SRPT) — JPMorgan raised its price target from $20.00 to $22.00, maintaining a Neutral rating.
SoundThinking (SSTI) — Cantor Fitzgerald withdrew its coverage.
Swarmer (SWMR) — Oppenheimer initiated coverage with an Outperform rating and a price target of $20.00.
BBB Foods (TBBB) — Barclays initiated coverage with an Overweight rating and a price target of $90.00.
Teladoc Health (TDOC) — Truist raised its price target from $8.00 to $9.00, maintaining a Hold rating.
Atlassian (TEAM) — UBS initiated coverage with a Neutral rating and adjusted its price target from $160.00 to $150.00.
Tempus AI (TEM) — H.C. Wainwright maintained its Buy rating with a price target of $85.00.
Teva Pharmaceutical Industries (TEVA) — Barclays raised its price target from $47.00 to $50.00, maintaining an Overweight rating.
Target (TGT) — Baird raised its price target from $175.00 to $180.00, maintaining a Neutral rating.
Target (TGT) — Bernstein raised its price target from $154.00 to $160.00, maintaining a Market Perform rating.
Target (TGT) — BTIG Research maintained its Neutral rating.
Target (TGT) — KGI Securities upgraded the stock from Neutral to Outperform, with a price target of $195.00.
Target (TGT) — Truist raised its price target from $167.00 to $172.00, maintaining a Hold rating.
Target (TGT) — Guggenheim raised its price target from $175.00 to $180.00, maintaining a Buy rating.
Target (TGT) — BMO Capital Markets raised its price target from $160.00 to $170.00, maintaining a Market Perform rating.
Target (TGT) — Bank of America raised its price target from $141.00 to $145.00, maintaining an Underperform rating.
Target (TGT) — BNP Paribas Exane updated its price target from $128.00 to $130.00, maintaining an Underperform rating.
Target (TGT) — Morgan Stanley raised its price target from $170.00 to $185.00, maintaining an Overweight rating.
Target (TGT) — DA Davidson raised its price target from $185.00 to $198.00, maintaining a Buy rating.
Target (TGT) — TD Cowen raised its price target from $160.00 to $175.00, maintaining a Hold rating.
Target (TGT) — Piper Sandler raised its price target from $153.00 to $176.00, maintaining a Neutral rating.
Target (TGT) — RBC Capital Markets raised its price target from $178.00 to $183.00, maintaining an Outperform rating.
Target (TGT) — Mizuho raised its price target from $150.00 to $168.00, maintaining a Neutral rating.
TJX Companies (TJX) — Wells Fargo set a price target of $135.00, with a Cautious rating.
TJX Companies (TJX) — Barclays lowered its price target from $188.00 to $186.00, maintaining an Overweight rating.
TJX Companies (TJX) — BTIG Research maintained its Buy rating with a price target of $190.00.
TJX Companies (TJX) — Guggenheim maintained its Buy rating with a price target of $152.00.
Tencent Music Entertainment Group (TME) — Barclays lowered its price target from $20.00 to $19.00, maintaining an Overweight rating.
TransUnion (TRU) — Barclays raised its price target from $70.00 to $82.00, maintaining an Equal Weight rating.
TELUS (TU) — National Bank Financial upgraded the stock from Sector Perform to Outperform.
Texas Roadhouse (TXRH) — JPMorgan lowered its price target from $200.00 to $195.00, maintaining a Neutral rating.
Uber Technologies (UBER) — Citizens Jmp set a price target of $100.00.
Uber Technologies (UBER) — Citigroup maintained its Market Outperform rating.
Unusual Machines (UMAC) — Oppenheimer initiated coverage with an Outperform rating and a price target of $30.00.
Unum Group (UNM) — UBS upgraded the stock from Neutral to Buy and adjusted its price target from $94.00 to $111.00.
Upbound Group (UPBD) — Loop Capital downgraded the stock from Buy to Hold, with a price target of $26.00.
Upstart (UPST) — Truist set a price target of $30.00.
Universal Technical Institute (UTI) — Rosenblatt Securities set a price target of $35.00.
Universal Technical Institute (UTI) — Lake Street Capital lowered its price target from $37.00 to $29.00, maintaining a Buy rating.
Universal Technical Institute (UTI) — B. Riley Financial lowered its price target from $45.00 to $39.00, maintaining a Buy rating.
Veeva Systems (VEEV) — UBS initiated coverage with a Neutral rating and adjusted its price target from $325.00 to $310.00.
Viking (VIK) — Citigroup lowered its price target from $113.00 to $111.00, maintaining a Buy rating.
Viking (VIK) — StoneX raised its price target from $99.00 to $106.00, maintaining a Buy rating.
Viking (VIK) — Bernstein maintained its Outperform rating.
Viridian Therapeutics (VRDN) — Bank of America initiated coverage with a Buy rating and a price target of $47.00.
Valvoline (VVV) — TD Cowen set a price target of $40.00, with a Buy rating.
Valvoline (VVV) — Jefferies Financial Group set a price target of $45.00, with a Buy rating.
Vylor (VYLR) — Barclays initiated coverage with an Overweight rating and a price target of $83.00.
Workday (WDAY) — Barclays lowered its price target from $224.00 to $223.00, maintaining an Overweight rating.
Walmart (WMT) — TD Cowen set a price target of $125.00, with a Buy rating.
Willis Towers Watson Public (WTW) — Wells Fargo raised its price target from $360.00 to $390.00, maintaining an Overweight rating.
Woodward (WWD) — UBS raised its price target from $455.00 to $467.00, maintaining a Buy rating.
Woodward (WWD) — Jefferies Financial Group set a price target of $425.00, with a Buy rating.
Xencor (XNCR) — JPMorgan raised its price target from $21.00 to $37.00, maintaining a Neutral rating.
XP (XP) — JPMorgan lowered its price target from $38.00 to $18.00, maintaining an Overweight rating.
Zai Lab (ZLAB) — JPMorgan raised its price target from $36.00 to $37.00, maintaining an Overweight rating.
Zoom Communications (ZM) — StoneX raised its price target from $125.00 to $130.00, maintaining a Buy rating.

STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.






